Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way

The biopharmaceutical classification of drugs was designed as a basis for bio-waivers – a mechanism with the double ethical benefit of delivering new drug formulations to the market with less human testing and lower cost. However, many drugs defy simple classification because in vitro permeability a...

Full description

Bibliographic Details
Main Authors: Berginc Katja, Sibinovska Nadica, Žakelj Simon, Trontelj Jurij, Legen Igor
Format: Article
Language:English
Published: Sciendo 2020-06-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2020-0006
_version_ 1826841536840597504
author Berginc Katja
Sibinovska Nadica
Žakelj Simon
Trontelj Jurij
Legen Igor
author_facet Berginc Katja
Sibinovska Nadica
Žakelj Simon
Trontelj Jurij
Legen Igor
author_sort Berginc Katja
collection DOAJ
description The biopharmaceutical classification of drugs was designed as a basis for bio-waivers – a mechanism with the double ethical benefit of delivering new drug formulations to the market with less human testing and lower cost. However, many drugs defy simple classification because in vitro permeability and stability assessment can be challenging as shown in this study for desloratadine. Literature shows that desloratadine is highly soluble, while data on luminal stability and permeability are circumstantial. Combined with borderline bioavailability and not really known fraction of absorbed dose, desloratadine was found to be a good example for showing the innovative in vitro approaches necessary to unambiguously classify desloratadine according to Biopharmaceutical Classification System (BCS) guideline. Presented study undoubtedly confirmed that desloratadine solubility is high and dissolution is very rapid for immediate release reference tablets. We have demonstrated deslorata-dine stability under legally required conditions and also in more physiologically relevant media. High in vitro desloratadine permeability was confirmed using Caco-2 and Parallel Artificial Membrane Permeability Assay (PAMPA). Well-established in vitro model with rat intestinal tissue could not be used due to reasons elaborated in this paper.
first_indexed 2024-12-16T08:59:02Z
format Article
id doaj.art-cd13a55fa8514ce181c91413480d4460
institution Directory Open Access Journal
issn 1846-9558
language English
last_indexed 2025-02-16T13:03:27Z
publishDate 2020-06-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj.art-cd13a55fa8514ce181c91413480d44602025-02-02T15:49:11ZengSciendoActa Pharmaceutica1846-95582020-06-0170213114410.2478/acph-2020-0006acph-2020-0006Biopharmaceutical classification of desloratadine – not all drugs are classified the easy wayBerginc Katja0Sibinovska Nadica1Žakelj Simon2Trontelj Jurij3Legen Igor4Lek d.d., 1526 Ljubljana, SloveniaLek d.d., 1526 Ljubljana, SloveniaUniversity of Ljubljana, Faculty of Pharmacy, Chair of Biopharmaceutics and Pharmacokinetics, SI- 1000 LjubljanaSloveniaUniversity of Ljubljana, Faculty of Pharmacy, Chair of Biopharmaceutics and Pharmacokinetics, SI- 1000 LjubljanaSloveniaLek d.d., 1526 Ljubljana, SloveniaThe biopharmaceutical classification of drugs was designed as a basis for bio-waivers – a mechanism with the double ethical benefit of delivering new drug formulations to the market with less human testing and lower cost. However, many drugs defy simple classification because in vitro permeability and stability assessment can be challenging as shown in this study for desloratadine. Literature shows that desloratadine is highly soluble, while data on luminal stability and permeability are circumstantial. Combined with borderline bioavailability and not really known fraction of absorbed dose, desloratadine was found to be a good example for showing the innovative in vitro approaches necessary to unambiguously classify desloratadine according to Biopharmaceutical Classification System (BCS) guideline. Presented study undoubtedly confirmed that desloratadine solubility is high and dissolution is very rapid for immediate release reference tablets. We have demonstrated deslorata-dine stability under legally required conditions and also in more physiologically relevant media. High in vitro desloratadine permeability was confirmed using Caco-2 and Parallel Artificial Membrane Permeability Assay (PAMPA). Well-established in vitro model with rat intestinal tissue could not be used due to reasons elaborated in this paper.https://doi.org/10.2478/acph-2020-0006desloratadinebcs-based bio-waiverluminal stabilitypermeabilitydissolution
spellingShingle Berginc Katja
Sibinovska Nadica
Žakelj Simon
Trontelj Jurij
Legen Igor
Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
Acta Pharmaceutica
desloratadine
bcs-based bio-waiver
luminal stability
permeability
dissolution
title Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
title_full Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
title_fullStr Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
title_full_unstemmed Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
title_short Biopharmaceutical classification of desloratadine – not all drugs are classified the easy way
title_sort biopharmaceutical classification of desloratadine not all drugs are classified the easy way
topic desloratadine
bcs-based bio-waiver
luminal stability
permeability
dissolution
url https://doi.org/10.2478/acph-2020-0006
work_keys_str_mv AT berginckatja biopharmaceuticalclassificationofdesloratadinenotalldrugsareclassifiedtheeasyway
AT sibinovskanadica biopharmaceuticalclassificationofdesloratadinenotalldrugsareclassifiedtheeasyway
AT zakeljsimon biopharmaceuticalclassificationofdesloratadinenotalldrugsareclassifiedtheeasyway
AT tronteljjurij biopharmaceuticalclassificationofdesloratadinenotalldrugsareclassifiedtheeasyway
AT legenigor biopharmaceuticalclassificationofdesloratadinenotalldrugsareclassifiedtheeasyway